Toll-like receptor-mediated tumor necrosis factor and interleukin-10 production differ during systemic inflammation

American Journal of Respiratory and Critical Care Medicine

Volumn 168, Issue 2, 2003, Pages 158-164

  Adib Conquy, Minou ^a   Moine, Pierre ^b   Asehnoune, Karim ^b   Edouard, Alain ^b   Espevik, Terje ^b   Miyake, Kensuke ^b   Werts, Catherine ^b   Cavaillon, Jean Marc ^b  

^a UP Cytokines and inflammation   (France)

^b NONE

Author keywords

LPS; p38 mitogen activated protein kinase; Toll like receptor 9; Trauma

Indexed keywords

BACTERIAL DNA; ENDOTOXIN; ESCHERICHIA COLI ENDOTOXIN; INTERLEUKIN 10; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR SP1; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ESCHERICHIA COLI; FEMALE; HUMAN; INFLAMMATION; INJURY; LEPTOSPIRA INTERROGANS; LEUKOCYTE; MALE; MONOCYTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATION;

ADULT; APACHE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; INFLAMMATION; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; MALE; MEMBRANE GLYCOPROTEINS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA; WOUNDS AND INJURIES;

EID: 0043167831     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200209-1077OC     Document Type: Article

References (46)

1. Sauaia A, Moore FA, Moore EE, Moser KS, Brennan R, Read RA, Pons PT. Epidemiology of trauma deaths: a reassessment. J Trauma 1995;38:185-193.
2. Regel G, Lobenhoffer P, Grotz M, Pape HC, Lehmann U, Tscherne H. Treatment results of patients with multiple trauma: an analysis of 3406 cases treated between 1972 and 1991 at a German level I trauma center. J Trauma 1995;38:70-78.
3. Muñoz C, Cadet J, Fitting C, Misset B, Bleriot JP, Cavaillon JM. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 1991;88:1747-1754.
4. Marie C, Muret J, Fitting C, Losser M-R, Payen D, Cavaillon J-M. Reduced ex vivo interleukin-8 production by neutrophils in septic and non-septic systemic inflammatory response syndrome. Blood 1998;91:3439-3446.
5. Chaudry IH, Ayala A. Mechanism of increased susceptibility to infection following hemorrhage. Am J Surg 1993;165:59S-67S.
6. Keel M, Schregenberger N, Steckholzer U, Ungethum U, Kenney J, Trentz O, Ertel W. Endotoxin tolerance after severe injury and its regulatory mechanisms. J Trauma 1996;41:430-438.
7. Miller LS, Morita Y, Rangan U, Kondo S, Clemens MG, Bulkley GB. Suppression of cytokine-induced neutrophil accumulation in rat mesenteric venules in vivo by general anesthesia. Int J Microcirc Clin Exp 1996;16:147-154.
8. Moore FA, Moore EE, Sauaia A. Blood transfusion: an independent risk factor for postinjury multiple organ failure. Arch Surg 1997;132:620-624.
9. Bencsics A, Elenkov IJ, Vizi ES. Effect of morphine on lipopolysaccharide-induced tumor necrosis factor-alpha production in vivo: involvement of the sympathetic nervous system. J Neuroimmunol 1997;73:1-6.
10. Hershman MJ, Cheadle WG, Wellhausen SR, Davidon P, Polk HC. Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patients. Br J Surg 1990;77:204-207.
11. McCall CE, Grosso-Wilmoth LM, LaRue K, Guzman RN, Cousart SL. Tolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome. J Clin Invest 1993;91:853-861.
12. De AK, Kodys K, Puyana JC, Fudem G, Savoie P, Miller-Graziano CL. Elevated IL-8 production by trauma patients' monocytes is associated with elevated secretion of TNF alpha. Shock 1995;4:171-177.
13. Astiz M, Saha D, Lustbader D, Lin R, Rackow E. Monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsis. J Lab Clin Med 1996;128:597-600.
14. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutation in Tlr4 gene. Science 1998;282:2085-2088.
15. Yang R-B, Mark MR, Gray A, Huang A, Xie MH, Zhang M, Goddard A, Wood WI, Gurney AL, Godowski PJ. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signaling. Nature 1998;395:284-288.
16. Lien E, Sellati TJ, Yoshimura A, Flo TH, Rawadi G, Finberg RW, Caroll JD, Espevik T, Ingalls RR, Radolf JD, et al. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 1999;274:33419-33425.
17. Ingalls RR, Lien E, Golenbock DT. Membrane-associated proteins of a lipopolysaccharide-deficient mutant of Neisseria meningitidis activate the inflammatory response through toll-like receptor 2. Infect Immun 2001;69:2230-2236.
18. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 1999;274:17406-17409.
19. Flo TH, Halaas O, Lien E, Ryan L, Teti G, Golenbock DT, Sundan A, Espevik T. Human Toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide. J Immunol 2000;164:2064-2069.
20. Werts C, Tapping RI, Mathison JC, Chuang T-H, Kravchenko V, Saint Girons I, Haake DA, Godowski PJ, Hayashi F, Ozinsky A, et al. Leptospiral lipolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol 2001;2:346-352.
21. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, et al. A toll-like receptor recognizes bacterial DNA. Nature 2000;408:740-745.
22. van Dissel JT, van Langevelde P, Westendorp RG, Kwappenberg K, Frolich M. Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 1998;351:950-953.
23. Adib-Conquy M, Adrie C, Moine P, Asehnoune K, Fitting C, Pinsky MR, Dhainaut J-F, Cavaillon J-M. NF-κB expression in mononuclear cells of septic patients resembles that observed in LPS-tolerance. Am J Respir Crit Care Med 2000;162:1877-1883.
24. Adib-Conquy M, Asehnoune K, Moine P, Cavaillon J-M. Long-term-impaired expression of nuclear factor-κ B and IκBα in peripheral blood mononuclear cells of trauma patients. J Leukoc Biol 2001;70:30-38.
25. Brightbill HD, Plevy SE, Modlin RL, Smale ST. A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages. J Immunol 2000;164:1940-1951.
26. Ma W, Lim W, Gee K, Aucoin S, Nandan D, Kozlowski M, Diaz-Mitoma F, Kumar A. The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp-1 transcription factor in lipopolysaccharide-stimulated human macrophages. J Biol Chem 2001;276:13664-13674.
27. Baker SP, O'Neill B, Long WB. The Injury Severity Score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 1974;14:187-196.
28. Akashi S, Ogata H, Kirikae F, Kirikae T, Kawasaki K, Nishjima M, Shimazu R, Nagai Y, Fukudome K, Kimoto M, et al. Regulatory roles for CD14 and phosphatidylinositol in the signaling via toll-like receptor 4-MD-2. Biochem Biophys Res Commun 2000;268:172-177.
29. Adib-Conquy M, Petit A-F, Marie C, Fitting C, Cavaillon J-M. Paradoxical priming effects of Il-10 on cytokine production. Int Immunol 1999;11:689-698.
30. Cavaillon J-M, Pitton C, Fitting C. Endotoxin tolerance is not a LPS-specific phenomenon: partial mimicry with IL-1, IL-10 and TGFb. J Endotoxin Res 1994;1:21-29.
31. Corvol H, Fitting C, Chadelat K, Jacquot J, Tabary O, Boule M, Cavaillon J-M, Clément A. Distinct cytokine production by lung and blood neutrophils from children with cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 2003;284:L997-L1003.
32. Armitage P, Berry G, Matthews JNS. Statistical methods in medical research, 4th ed. London: Blackwell Science: 2002.
33. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 1995;364:229-233.
34. Vlahos CJ, Matter WF, Hui KY, Brown RF. A specific inhibitor of phosphatidylinositol 3-kinase,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (Ly294002). J Biol Chem 1994;269:5241-5248.
35. Neer EJ, Clapham DE. Roles of G protein subunits in transmembrane signalling. Nature 1988;333:129-134.
36. Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M, Nakanishi K, Kimoto M, Miyake K, Takeda K, et al. Endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol 2000;164:3476-3479.
37. Martin M, Katz J, Vogel SN, Michalek SM. Differential induction of endotoxin tolerance by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli. J Immunol 2001;167:5278-5285.
38. Dybdahl B, Wahba A, Lien E, Flo TH, Waage A, Qureshi N, Sellevold OFM, Espevik T, Sundan A. Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through toll-like receptor-4. Circulation 2002;105:685-690.
39. Tone M, Powell MJ, Tone Y, Thompson SAJ, Waldmann H. IL-10 gene expression is controled by the transcription factors Sp1 and Sp3. J Immunol 2000;165:286-291.
40. Foey AE, Parry SL, Williams LM, Feldmann M, Foxwell BMJ, Brennan FM. Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNFα: role of the p38 and p42/44 mitogen-activated protein kinases. J Immunol 1998;160:920-928.
41. q/11 subunits. J Biol Chem 1997;272:27771-27777.
42. Solomon KR, Kurt-Jones EA, Saladino RA, Stack AM, Dunn IF, Ferretti M, Golenbock D, Fleisher GR, Finberg RW. Heterotrimeric G proteins physically associated with the lipopolysaccharide receptor CD14 modulate both in vivo and in vitro responses to lipopolysaccharide. J Clin Invest 1998;102:2019-2027.
43. Chun YK, Kim J, Kwon S, Choi SH, Hong F, Moon K, Kim JM, Choi SL, Kim BS, Ha J, et al. Phosphatidylinositol 3-kinase stimulates muscle differentiation by activating p38 mitogen-activated protein kinase. Biochem Biophys Res Commun 2000;276:502-507.
44. Hirasawa N, Sato Y, Fujita Y, Ohuchi K. Involvement of a phosphatidylinositol 3-kinase-p38 mitogen activated protein kinase pathway in antigen-induced IL-4 production in mast cells. Biochim Biophys Acta 2000;1456:45-55.
45. Bowling WM, Hafenrichter DG, Flye MW, Callery MP. Endotoxin tolerance alters phospholipase C-gamma 1 and phosphatidylinositol-3′-kinase expression in peritoneal macrophages. J Surg Res 1995;58:592-598.
46. Learn CA, Boger MS, Li L, McCall CE. The phosphatidylinositol 3-kinase pathway selectively controls sIL-1ra not interleukin-1β production in the septic leukocytes. J Biol Chem 2001;276:20234-20239.